US Stock MarketDetailed Quotes

IDYA IDEAYA Biosciences

Watchlist
  • 42.740
  • +1.850+4.52%
Close Jul 22 16:00 ET
3.59BMarket Cap-21370P/E (TTM)

IDEAYA Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
-54.08%23.39M
-2.49%3.92M
-72.94%8.04M
-39.43%3.54M
-30.63%7.88M
82.28%50.93M
35.79%4.02M
230.87%29.7M
-33.18%5.85M
Operating revenue
--0
-54.08%23.39M
-2.49%3.92M
-72.94%8.04M
-39.43%3.54M
-30.63%7.88M
82.28%50.93M
35.79%4.02M
230.87%29.7M
-33.18%5.85M
Cost of revenue
Gross profit
Operating expense
49.35%51.02M
39.13%157.81M
50.46%45.84M
43.13%41.56M
27.88%36.25M
33.54%34.16M
45.04%113.43M
42.82%30.47M
40.36%29.04M
43.13%28.35M
Selling and administrative expenses
30.35%8.21M
18.45%28.31M
22.90%7.07M
17.94%7.86M
27.39%7.08M
6.37%6.3M
19.18%23.9M
10.17%5.75M
28.56%6.67M
15.04%5.55M
-General and administrative expense
30.35%8.21M
18.45%28.31M
22.90%7.07M
17.94%7.86M
27.39%7.08M
6.37%6.3M
19.18%23.9M
10.17%5.75M
28.56%6.67M
15.04%5.55M
Research and development costs
53.65%42.81M
44.64%129.51M
56.88%38.77M
50.64%33.7M
28.00%29.18M
41.73%27.86M
53.95%89.54M
53.40%24.71M
44.31%22.37M
52.19%22.8M
Operating profit
-94.14%-51.02M
-115.08%-134.43M
-58.52%-41.92M
-5,179.70%-33.53M
-45.38%-32.71M
-84.80%-26.28M
-24.34%-62.5M
-43.95%-26.44M
105.63%660K
-103.59%-22.5M
Net non-operating interest income expense
333.69%11.45M
458.05%21.47M
255.13%7.96M
537.28%6.09M
979.68%4.78M
1,174.88%2.64M
660.28%3.85M
1,328.03%2.24M
629.01%955K
325.96%443K
Non-operating interest income
333.69%11.45M
458.05%21.47M
255.13%7.96M
537.28%6.09M
979.68%4.78M
1,174.88%2.64M
660.28%3.85M
1,328.03%2.24M
629.01%955K
325.96%443K
Other net income (expense)
-201.30%-1.49M
1.47M
Gain on sale of security
-201.30%-1.49M
----
----
----
----
--1.47M
----
----
----
----
Income before tax
-85.16%-41.06M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-58.24%-22.17M
-17.87%-58.66M
-32.88%-24.2M
113.94%1.62M
-101.48%-22.06M
Income tax
Net income
-85.16%-41.06M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-58.24%-22.17M
-17.87%-58.66M
-32.88%-24.2M
113.94%1.62M
-101.48%-22.06M
Net income continuous Operations
-85.16%-41.06M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-58.24%-22.17M
-17.87%-58.66M
-32.88%-24.2M
113.94%1.62M
-101.48%-22.06M
Minority interest income
Net income attributable to the parent company
-85.16%-41.06M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-58.24%-22.17M
-17.87%-58.66M
-32.88%-24.2M
113.94%1.62M
-101.48%-22.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-85.16%-41.06M
-92.59%-112.96M
-40.30%-33.96M
-1,799.07%-27.44M
-26.61%-27.93M
-58.24%-22.17M
-17.87%-58.66M
-32.88%-24.2M
113.94%1.62M
-101.48%-22.06M
Basic earnings per share
-8.16%-0.53
-38.03%-1.96
-4.00%-0.52
-1,250.00%-0.46
12.28%-0.5
-36.11%-0.49
-0.71%-1.42
-6.38%-0.5
112.90%0.04
-72.73%-0.57
Diluted earnings per share
-8.16%-0.53
-38.03%-1.96
-4.00%-0.52
-1,250.00%-0.46
12.28%-0.5
-36.11%-0.49
-0.71%-1.42
-6.38%-0.5
112.90%0.04
-72.73%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0-54.08%23.39M-2.49%3.92M-72.94%8.04M-39.43%3.54M-30.63%7.88M82.28%50.93M35.79%4.02M230.87%29.7M-33.18%5.85M
Operating revenue --0-54.08%23.39M-2.49%3.92M-72.94%8.04M-39.43%3.54M-30.63%7.88M82.28%50.93M35.79%4.02M230.87%29.7M-33.18%5.85M
Cost of revenue
Gross profit
Operating expense 49.35%51.02M39.13%157.81M50.46%45.84M43.13%41.56M27.88%36.25M33.54%34.16M45.04%113.43M42.82%30.47M40.36%29.04M43.13%28.35M
Selling and administrative expenses 30.35%8.21M18.45%28.31M22.90%7.07M17.94%7.86M27.39%7.08M6.37%6.3M19.18%23.9M10.17%5.75M28.56%6.67M15.04%5.55M
-General and administrative expense 30.35%8.21M18.45%28.31M22.90%7.07M17.94%7.86M27.39%7.08M6.37%6.3M19.18%23.9M10.17%5.75M28.56%6.67M15.04%5.55M
Research and development costs 53.65%42.81M44.64%129.51M56.88%38.77M50.64%33.7M28.00%29.18M41.73%27.86M53.95%89.54M53.40%24.71M44.31%22.37M52.19%22.8M
Operating profit -94.14%-51.02M-115.08%-134.43M-58.52%-41.92M-5,179.70%-33.53M-45.38%-32.71M-84.80%-26.28M-24.34%-62.5M-43.95%-26.44M105.63%660K-103.59%-22.5M
Net non-operating interest income expense 333.69%11.45M458.05%21.47M255.13%7.96M537.28%6.09M979.68%4.78M1,174.88%2.64M660.28%3.85M1,328.03%2.24M629.01%955K325.96%443K
Non-operating interest income 333.69%11.45M458.05%21.47M255.13%7.96M537.28%6.09M979.68%4.78M1,174.88%2.64M660.28%3.85M1,328.03%2.24M629.01%955K325.96%443K
Other net income (expense) -201.30%-1.49M1.47M
Gain on sale of security -201.30%-1.49M------------------1.47M----------------
Income before tax -85.16%-41.06M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-58.24%-22.17M-17.87%-58.66M-32.88%-24.2M113.94%1.62M-101.48%-22.06M
Income tax
Net income -85.16%-41.06M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-58.24%-22.17M-17.87%-58.66M-32.88%-24.2M113.94%1.62M-101.48%-22.06M
Net income continuous Operations -85.16%-41.06M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-58.24%-22.17M-17.87%-58.66M-32.88%-24.2M113.94%1.62M-101.48%-22.06M
Minority interest income
Net income attributable to the parent company -85.16%-41.06M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-58.24%-22.17M-17.87%-58.66M-32.88%-24.2M113.94%1.62M-101.48%-22.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -85.16%-41.06M-92.59%-112.96M-40.30%-33.96M-1,799.07%-27.44M-26.61%-27.93M-58.24%-22.17M-17.87%-58.66M-32.88%-24.2M113.94%1.62M-101.48%-22.06M
Basic earnings per share -8.16%-0.53-38.03%-1.96-4.00%-0.52-1,250.00%-0.4612.28%-0.5-36.11%-0.49-0.71%-1.42-6.38%-0.5112.90%0.04-72.73%-0.57
Diluted earnings per share -8.16%-0.53-38.03%-1.96-4.00%-0.52-1,250.00%-0.4612.28%-0.5-36.11%-0.49-0.71%-1.42-6.38%-0.5112.90%0.04-72.73%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg